期刊文献+

细菌药物钝化酶基因分布及其表达诱导与抑制机制的研究 被引量:6

Distribution of drug inactive enzyme genes in bacterial isolates and mechanism of its induction and inhibition
下载PDF
导出
摘要 目的:了解临床常见病原菌药物钝化酶基因及其优势基因携带模式,抗生素诱导药物钝化酶基因表达上调的作用及其与细菌组氨酸激酶的关系。方法:采用PCR和测序法,了解金黄色葡萄球菌、大肠埃希菌、肺炎克雷伯菌、鲍曼不动杆菌、阴沟肠杆菌临床菌株携带的β-内酰胺类、氨基糖苷类、大环内酯类钝化酶基因。采用实时荧光定量RT-PCR,了解抗生素诱导及组氨酸激酶阻断剂氯氰碘柳胺抑制药物钝化酶基因表达的作用。结果:63株大肠埃希菌中检出4种β-内酰胺类、2种氨基糖苷类和1种大环内酯类钝化酶基因,优势基因携带模式为[TEM+CTX-M]+aac(3)-Ⅱ+mphA 16株(25.4%)和[TEM+CTX-M]+aac(6')-Ⅰb 13株(20.6%)。24株金黄色葡萄球菌中检出2种β-内酰胺类、3种氨基糖苷类钝化酶基因,优势基因携带模式为aph(3')(41.7%)或aac(6)-Ⅰe-aph(2)-Ⅰa(25.0%)。28株肺炎克雷伯菌中检出4种β-内酰胺酶、2种氨基糖苷类钝化酶基因,优势基因携带模式为[TEM+SHV]+[aac(6')-Ⅰb+aac(3)-Ⅱ](28.6%)和[TEM+SHV]+[aac(6')-Ⅰb+aac(3)-Ⅱ]+mphA(17.8%)。鲍曼不动杆菌和阴沟肠杆菌也以携带两类或三类药物钝化酶基因为优势模式。1/4 MIC青霉素、头胞噻肟和链霉素,能诱导3种β-内酰胺类和4种氨基糖苷类钝化酶基因表达显著上调(P<0.05),该诱导作用可被氯氰碘柳胺所抑制(P<0.05)。结论:上述临床常见病原菌多携带多类药物钝化酶基因并存在不同的优势基因携带模式。低浓度抗生素可能诱导药物钝化酶基因表达上调,但可被组氨酸激酶阻断剂所抑制。 Objective : To determine the distribution and the predominant gene carrying model of drug inactive enzyme genes in bacterial isolates, and the mechanism of its induction and inhibition. Methods: The β-lactam, aminoglycosides and macrolides inactive enzyme genes were detected by PCR and sequencing in S. aureus, E. coli, K. pncumoniae, A. baumanii and E. cloacae isolates. The expression of inactive enzyme genes were examined by real-time fluorescent quantitative RT-PCR when the bacterial isolates were treated with antibiotics or a histidine kinase blocker closantel. Results : In 63 isolates of E. coli ,4 kinds of β-lactam, 2 aminoglycosides and 1 macrolides inactive enzyme-encoding genes were detected and the predominant gene-carrying models were [TEM + CTX-M ] + aac (3)- II + mphA (25.4%) and ITEM + CTX-M] + aac(6')-I b(20.6%). In 24 isolates of S. aureus,2 kinds of β-lactam and 3 aminoglycosides inactive enzyme-encoding genes were detected and the predominant gene- carrying models were aph(3') (41.7%) or aac(6)- I e-aph(2)- I a(25.0% ). In 28 isolates of K. pncumoniae,4 kinds of β-lactam and 2 aminoglycosides inactive enzyme-encoding genes were detected and the predominant gene-carrying models were [TEM + SHV ] + [ aac (6')- I b + aac (3)- 11 ] (28.6%) and [ TEM + SHY 1 + [ aac (6')- I b + aac ( 3 )- II ] + mphA ( 17.8 % ). The isolates of A. baumanii and E. cloacae also had a predominant model to carry 2 or 3 kinds of inactive enzyme-encoding genes. 1/4 MIC of penicillin, cefotaxime or streptomycin induced the up-regulation of expression of 3 β-lactam or 4 aminoglycosides inactive enzyme-encoding genes ( P 〈 0.05 ) , and this effect was inhibited by closantel ( P 〈 0. 05 ). Conclusions: The bacterial isolates frequently carry multiple kinds of inactive enzyme- encoding genes with different predominant gene-carrying models. Low concentration antibiotics can induce the up-regulation of inactive enzyme gene expression, which can be inhibited by histidine kinase blocker.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2013年第2期131-140,共10页 Journal of Zhejiang University(Medical Sciences)
基金 国家自然科学基金资助项目(81271983) 浙江省自然科学基金资助项目(LY12H19002)
关键词 抗药性 细菌 遗传学 药物耐受性 基因型 基因表达 聚合酶链反应 细菌 耐药基因 检测 药物钝化酶 表达 调控机制 Drug resistance, bacterial/genetics Drug tolerance Genotype Gene expression Polymerase chain reaction Bacteria Resistance gene/detection Inactive enzyme/ expression Regulation mechanism
  • 相关文献

参考文献5

二级参考文献71

  • 1赵宗珉,赵金满,万建华.肺炎克雷伯杆菌肝脓肿与非肺炎克雷伯杆菌肝脓肿的临床比较[J].世界华人消化杂志,2006,14(16):1582-1586. 被引量:25
  • 2战微微,蒋天安,潘农.肺炎克雷伯杆菌肝脓肿超声诊断及介入治疗价值分析[J].浙江医学,2007,29(3):283-284. 被引量:4
  • 3HOSHINO K, WATANABE H, SUGITA R, et al. High rate of transmission of penicillin- resistant Streptococcus pneumoniae between parents and children [J]. J Clin Mierobio1,2002, 40(11):4357-4359.
  • 4THORUSBERRY C, JONES M B, HICKEY M L,et al. Resistance surveillance of Streptococcus pneumoniae , Haemophilus influenzae and Morazella catarrhalis isolated in the United States, 1997-1998 [J]. J Antimicrob Chemother, 1999,44 (6) : 749-759.
  • 5LEE N Y,SONG J H,KIM S,et al. Carriage of antibiotic resistant pneumocoeci among Asian children: a multinational surveillance by the Asian network for surveillance of resistant pathogens (ANSORP) [J]. Clin Infect Dis, 2001,32(10):1463-1468.
  • 6GUENZI E,GASC A M,SICARD M A,et al. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae [J. Mol Microbiol, 1994,12(3):505-515.
  • 7GIAMMARINARO P,SICARD M,GASC A M. Genetic and physiological studies of the CiaH- CiaR two-component signal-transducing system involved in cefotaxime resistance and competence of Streptococcus pneumoniae [J]. Microbiology, 1999,145(Pt 8):1859-1869.
  • 8AHN S J,WEN Z T,BURNE R A. Multilevel control of competence development and stress tolerance in Streptococcus mutans UA159[J]. Infect lmmun, 2006,74 ( 3 ): 1631-1642.
  • 9PATERSON G K,BLUE C E,MITCHELL T J. Role of two component systems in the virulence of Streptococcus pneumoniae[J].J Med Microbiol, 2006,55(pt 4) : 355-363.
  • 10SAMBROOK J,FRITSCH E F, MANIATIS T. Molecular CIoning,A Laboratory Manual [M]. New York: Gold Spring Harbor Laboratory Press,1989:1.21-1.52,2.60 2.80,7.30-7.35,9. 14-9.22.

共引文献88

同被引文献88

  • 1胡大春,邵剑春,杨绍敏,周玲,李超,刘德华.肺炎克雷伯菌超广谱β-内酰胺酶基因型研究[J].中国抗生素杂志,2006,31(1):19-22. 被引量:26
  • 2石蓉林,陈淑贞,蔡应木,刘幸平,钱元恕.产超广谱β-内酰胺酶肺炎克雷伯菌临床菌株耐药表型与基因型[J].中华医院感染学杂志,2007,17(7):771-774. 被引量:12
  • 3Koczura R, Mokracka J, Kaznowski A. The Yersinia high-pathoge- nicity island in Escherichia coli and Klebsiella pneumoniae isolated from polymicrobial infections. Pol J Microbiol, 2012, 61 ( 1 ) : 71- 73.
  • 4Wu HS, Wang FD, Tseng CP, et al. Characteristics of healthcare- associated and community-acquired Klebsiella pneumoniae bactere- mia in Taiwan. J Infect, 2012, 64(2) : 162-168.
  • 5Carpentier M, Appere V, Saliou P, et al. Outbreak of extended spectrum beta-lactamase-producing Klebsiella pneumoniae in an in- tensive care unit (Brest). Med Mal Infect, 2012, 42(10) : 501- 509.
  • 6Razazi K, Derde LP, Veraehten M, et al. Clinical impact and risk factors for colonization with extended-spectrum 13-1actamase-produ- cing bacteria in the intensive care unit. Intensive Care Med, 2012, 38(11) : 1769-1778.
  • 7Perez F, Endimiani A, Hujer KM, et al. The continuing chal- lenge of ESBLs. Curr Opin Pharmacol, 2007, 7(5) : 459-469.
  • 8Sheng WH, Badal RE, Hsueh PR, et al. Distribution of extend- ed-spectrum 13-1actamases, AmpC 13-1actamases, and carbapene- mases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Moni- toring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother, 2013, 57(7): 2981-2988.
  • 9Theodorou EC, Theodorou MC, Kyriakidis DA. Inhibition of the signal transduetion through the AtoSC system by histidine kinaseinhibitors in Escherichia coli. Cell Signal, 2011, 23 ( 8 ) : 1327- 1337.
  • 10Clinical and Laboratory Standards Institute. M100- S21Performan- ce standards for antimierobial susceptibility testing; 21st informa- tional supplement, Wayne: Clinical and Laboratory Standards In- stitute, 2011.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部